Alepatalin Ophthalmic Solution 0.2% (Olopatadine Hydrochloride) (Single-use), Alepatalin Ophthalmic Solution 0.2% (Olopatadine Hydrochloride)

Adult eye dose

Instill 1 drop once a day.

This medicine should not be used by patients who have had allergic reactions to the active ingredient or any components of this medication. While using this medication, symptoms such as headaches, taste disturbances, and dizziness may occur. With regard to the eyes, symptoms such as punctate keratitis, keratitis, eye pain, dry eyes, itching eyes, increased eye discharge, eye congestion, and eyelid swelling may occur not infrequently. Additionally, symptoms such as glare, blurred vision, and eyelid erythema may occur rarely. Symptoms like nasal dryness, rhinitis, dry mouth, contact dermatitis, and fatigue have also been reported. After instilling this medication, symptoms similar to a cold and pharyngitis can occur in about 10% of users, as well as conjunctivitis, lethargy, lower back pain, flu-like symptoms, frequent coughing, infections, nausea, and sinusitis in some patients. This medication contains phosphates, which may cause a rare side effect of corneal calcification in patients with severe corneal damage, so caution is advised. It is advisable not to use this medication while wearing contact lenses, and particularly for soft contact lens users, they should wait at least 15 minutes after instillation before putting in the lenses. Benzalkonium chloride included in this medication may cause eye irritation and discoloration of contact lenses, so caution is necessary. Temporary blurred vision may occur after instillation, so one should wait until vision returns to normal before driving or operating machinery. Research on drug interactions with this medication has not yet been conducted. Pregnant women should carefully consider the risks and benefits this medication may pose to the fetus before use, and breastfeeding women must also be cautious as the medication can be transmitted through breast milk. It can be safely used in children over 3 years of age, and the elderly can use it without special precautions. In the case of an overdose, immediate medical observation and management are necessary. This medication is intended for direct instillation into the eyes only, and care should be taken not to let the opening of the container touch the area around the eyes, and the cap should be closed tightly after use. When using with other ophthalmic preparations, a minimum interval of 5 minutes should be maintained, and ointments should be used last. For single-use products, each should be used only once after opening, and the first drop should be discarded to remove any fragments of the container. When not in use, the cap should be tightly closed for storage.

Mild side effects

• Headache
• taste disturbances
• dizziness
• punctate keratitis
• keratitis
• eye pain
• dry eyes
• eyelid swelling
• itchy eyes
• eye discharge

This medication should be stored in a sealed container to prevent air and moisture from entering, ideally in a cool place between 2 and 25 degrees Celsius. This way of storage helps maintain the effectiveness of the medication and prevents deterioration.

Appearance

[Multiple-use] Colorless or slightly yellow ophthalmic solution in an opaque white container [Single-use] Colorless to slightly yellow clear liquid in a colorless transparent plastic container

Package unit

Multiple-use - 3 milliliters/bottle, Single-use - 0.3 milliliters/unit [0.3mL/tube × 10EA]